INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 86 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,824,000 | -45.7% | 298,937 | -15.6% | 0.04% | -42.9% |
| Q3 2016 | $3,357,000 | +24.1% | 354,148 | -2.6% | 0.06% | +12.5% |
| Q2 2016 | $2,706,000 | +14.0% | 363,757 | +13.4% | 0.06% | +5.7% |
| Q1 2016 | $2,374,000 | +24.4% | 320,759 | +90.5% | 0.05% | +17.8% |
| Q4 2015 | $1,908,000 | +38.5% | 168,405 | +14.8% | 0.04% | +36.4% |
| Q3 2015 | $1,378,000 | – | 146,645 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|